Survey of drug-related problems identified by community pharmacies

被引:65
作者
Haemmerlein, Andrea
Griese, Nina
Schulz, Martin
机构
[1] ABDA Fed Union German Assoc Pharm, Ctr Drug Informat & Pharm Practice ZAPP, D-10117 Berlin, Germany
[2] Goethe Univ Frankfurt, Dept Pharmacol, Mainz, Germany
关键词
ambulatory care; community pharmacy; drug-related problems; drug safety; medication error;
D O I
10.1345/aph.1K207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BACKGROUND: A drug-related problem (DRP) is defined as an event or circumstance that actually or potentially interferes with desired health outcomes. DRPs can lead to ineffective pharmacotherapy and may cause drug-related morbidity and mortality. Most DRPs are avoidable and community pharmacies are assuming an active role in preventing and solving DRPs. OBJECTIVE: To identify the spectrum of DRPs encountered in community pharmacies. METHODS: In 2005, a nationwide survey in Germany was conducted in community pharmacies to record all identified DRPs. Participating community pharmacies were free to select one week within the designated study period (February-May) and were instructed to record basic statistics (eg, number of patient interactions, number of prescriptions filled/nonprescription [over-the-counter; OTC] drugs dispensed per week), as well as patient-, problem-, and intervention-related data (eg, patient age and sex, whether a prescription-only or OTC drug was involved in the DRP, the time needed for problem resolution). DRPs were categorized using a modified version of the PI-Doc (problem-intervention-documentation) classification system. RESULTS: Community pharmacies that participated in the study (N = 1146) documented 10,427 DRPs (9.1 DRP per pharmacy per week). A broad spectrum of DRPs was identified, with 9 of 10 cases involving prescribed medicines. DRPs arose on 3 primary levels: the prescription-, the patient-, and the delivery level. Overall, drug-drug interactions were the most frequently reported DFIP (8.6%) and, according to community pharmacies, more than 80% of identified DRPs could be resolved completely. The prescribing physician was contacted in 60.5% of all such cases. Median time needed for solving a DFIP was 5 minutes. CONCLUSIONS: Pharmacists in the community pharmacy setting are well suited to identify and resolve DRPs. Ensuring the proper use of both prescription and OTC drugs is one of the basic responsibilities of pharmacists. This specific role of pharmacists within the healthcare system needs to be more fully recognized.
引用
收藏
页码:1825 / 1832
页数:8
相关论文
共 24 条
  • [1] *ABDATA PHARM DAT, 2005, ABDA DAT WERB VERTR
  • [2] Hospitalisations and emergency department visits due to drug-drug interactions: a literature review
    Becker, Matthijs L.
    Kallewaard, Marjon
    Caspers, Peter W. J.
    Visser, Loes E.
    Leufkens, Hubert G. M.
    Stricker, Bruno HCh
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (06) : 641 - 651
  • [3] Issues related to monitoring the safety of over-the-counter (OTC) medicines
    Bond, C
    Hannaford, P
    [J]. DRUG SAFETY, 2003, 26 (15) : 1065 - 1074
  • [4] Clinical risk management in Dutch community pharmacies - The case of drug-drug interactions
    Buurma, Henk
    De Smet, Peter A. G. M.
    Egberts, Antoine C. G.
    [J]. DRUG SAFETY, 2006, 29 (08) : 723 - 732
  • [5] DIENER F, 2006, PHARM ZTG, V151, P1658
  • [6] The price of innovation: new estimates of drug development costs
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 151 - 185
  • [7] Pharmaceutical care in community pharmacies: Practice and research in Germany 10.1 345/aph.1 G458
    Eickhoff, C
    Schulz, M
    [J]. ANNALS OF PHARMACOTHERAPY, 2006, 40 (04) : 729 - 735
  • [8] Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192
  • [9] Drug-related visits to the emergency department: How big is the problem?
    Fatel, P
    Zed, PJ
    [J]. PHARMACOTHERAPY, 2002, 22 (07): : 915 - 923
  • [10] Switching of prescription drugs to over-the-counter status - Is it a good thing for the elderly?
    Francis, SA
    Barnett, N
    Denham, M
    [J]. DRUGS & AGING, 2005, 22 (05) : 361 - 370